Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - TOTAL OTHER INCOME
Total Other Income IKT - Inhibikase Therapeutics, Inc.
1.06 M
LAST VALUE
643.31%
2 YEAR CAGR
105.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR